A 16-week ad libitum low-fat vegan dietary intervention in 25 adults with type 2 diabetes produced striking metabolic improvements across multiple organ systems. Body weight fell by 6.0 kg (6.6%), driven predominantly by fat loss (-4.2 kg), with visceral fat volume dropping 290 cm³. Hepatocellular lipids — liver fat — declined by 33%, fasting insulin resistance (HOMA-IR) fell by 2.5 units, and postprandial insulin sensitivity (PREDIM) rose by 1.3 mg/min/kg. Advanced glycation end-products, measured by skin fluorescence, also decreased significantly. Crucially, multiple parameters of beta-cell function improved, including glucose sensitivity, rate sensitivity, and potentiation factor.
The beta-cell finding is the most consequential here. Most dietary interventions for type 2 diabetes show peripheral and hepatic insulin sensitization through weight loss, but evidence of genuine beta-cell functional recovery is rarer and clinically more meaningful — it suggests the diet may address underlying pancreatic dysfunction, not merely compensate for it. The hepatic lipid reduction aligns with the "ectopic fat" model of type 2 diabetes pathogenesis championed by Roy Taylor's group, where liver fat drives insulin resistance upstream.
The critical limitation is the small, single-arm design (n=25, no control group), making it impossible to disentangle diet composition from caloric deficit effects. The Physicians Committee for Responsible Medicine affiliation introduces potential institutional bias. Nonetheless, the mechanistic depth — combining MRS, DXA, C-peptide deconvolution, and AGE fluorescence — elevates this above typical pilot work. A randomized trial against an isocaloric comparator is urgently needed.
